Photo from Jennifer Marks/X
Aug 4, 2024, 12:07
Jennifer Marks: Thyroid Cancer Highlights for Boards Early PTC/FTC
Jennifer Marks, Physician at shared a post on X:
“Thyroid Cancer Highlights for Boards Early PTC/FTC: Surgery + RAI + TSH Suppression in adv setting: 1L sorafenib; lenvatinib; 2L cabozantinib (PTC, FTC) 1L vandetanib; cabozantinib (MTC).”
Others:
- BRAF V600E (PTC>>ATC)
- RET (MTC)
- NTRK
- ALK
Source: Jennifer Marks/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14